A Clinicopathological Study on the Expression of Cadherin-17 and Caudal-related Homeobox Transcription Factor (CDX2) in Human Gastric Carcinoma

Clinical Oncology

Volumn 20, Issue 4, 2008, Pages 275-283

  Ge, Jie ^a   Chen, Zhikang ^a   Wu, Shaobin ^a   Yuan, Weijie ^a   Hu, Bin ^a   Chen, Zihua ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cadherin 17; CDX2; clinical pathology; gastric carcinoma; prognosis

Indexed keywords

CADHERIN; CADHERIN 17; PARAFFIN; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH WALL; SURVIVAL RATE;

ADULT; AGED; CADHERINS; CARCINOMA; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 41449090155     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.01.013     Document Type: Article

References (41)

1. Mutoh H., Sakurai S., Satoh K., et al. Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice. Cancer Res 64 (2004) 7740-7747
2. Chan A.O. E-cadherin in gastric cancer. World J Gastroenterol 12 (2006) 199-203
3. Ito R., Oue N., Yoshida K., et al. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer. Virchows Arch 447 (2005) 717-722
4. Wu Z.Y., Li J.H., Zhan W.H., et al. Effect of lymph node micrometastases on prognosis of gastric carcinoma. World J Gastroenterol 13 (2007) 4122-4125
5. Almeida R., Silva E., Santos-Silva F., et al. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol 199 (2003) 36-40
6. Freund J.N., Domon-Dell C., Kedinger M., et al. The Cdx-1 and Cdx-2 homeobox genes in the intestine. Biochem Cell Biol 76 (1998) 957-969
7. Bai Y.Q., Yamamoto H., Akiyama Y., et al. Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. Cancer Lett 176 (2002) 47-55
8. Kim H.S., Lee J.S., Freund J.N., et al. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions. J Gastroenterol Hepatol 21 (2006) 438-442
9. Eda A., Osawa H., Yanaka I., et al. Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia. J Gastroenterol 37 (2002) 94-100
10. Hinoi T., Lucas P.C., Kuick R., et al. CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology 123 (2002) 1565-1577
11. Conacci-Sorrell M., Zhurinsky J., and Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 109 (2002) 987-991
12. Tian M.M., Zhao A.L., Li Z.W., et al. Phenotypic classification of gastric signet ring cell carcinoma and its relationship with clinicopathologic parameters and prognosis. World J Gastroenterol 13 (2007) 3189-3198
13. Angres B., Kim L., Jung R., et al. LI-cadherin gene expression during mouse intestinal development. Dev Dyn 221 (2001) 182-193
14. Gessner R., and Tauber R. Intestinal cell adhesion molecules. Liver-intestine cadherin. Ann N Y Acad Sci 915 (2000) 136-143
15. Ko S., Chu K.M., Luk J.M., et al. CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach. J Pathol 205 (2005) 615-622
16. Seno H., Oshima M., Taniguchi M.A., et al. CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: prognostic implications. Int J Oncol 21 (2002) 769-774
17. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64 (1965) 31-49
18. Sobin L.H., and Wittekind C. UICC TNM classification of malignant tumors. 5th edn (1997), Wiley-Liss, New York p. 59-62
19. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer 1 (1998) 10-24
20. Shen H., Fan Y., Yang X., et al. Increased expression of cystic fibrosis transmembrane conductance regulator in rat liver after common bile duct ligation. J Cell Physiol 203 (2005) 599-603
21. Pei H., Zhu H., Zeng S., et al. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J Proteome Res 6 (2007) 2495-2501
22. Mizoshita T., Tsukamoto T., Inada K., et al. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no association to non-neoplastic surrounding mucosa. Pathol Int 54 (2004) 392-400
23. Silberg D.G., Sullivan J., Kang E., et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 122 (2002) 689-696
24. Matsuda Y., Semba S., Ueda J., et al. Gastric and intestinal claudin expression at the invasive front of gastric carcinoma. Cancer Sci 98 (2007) 1014-1019
25. Wong B.W., Luk J.M., Ng I.O., et al. Identification of liver-intestine cadherin in hepatocellular carcinoma-a potential disease marker. Biochem Biophys Res Commun 311 (2003) 618-624
26. Wang X.Q., Luk J.M., Leung P.P., et al. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma. Clin Cancer Res 11 (2005) 483-489
27. Takamura M., Sakamoto M., Ino Y., et al. Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas. Cancer Sci 94 (2003) 425-430
28. Bonhomme C., Duluc I., Martin E., et al. The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development. Gut 52 (2003) 1465-1471
29. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52 (1992) 6735-6740
30. Werling R.W., Yaziji H., Bacchi C.E., et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol 27 (2003) 303-310
31. Fan Z., Li J., Dong B., et al. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: association with histologic type and implications for prognosis. Clin Cancer Res 11 (2005) 6162-6170
32. Mutoh H., Hakamata Y., Sato K., et al. Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Commun 294 (2002) 470-479
33. Matsumoto K., Mizoshita T., Tsukamoto T., et al. Cdx2 expression in pancreatic tumors: relationship with prognosis of invasive ductal carcinomas. Oncol Rep 12 (2004) 1239-1243
34. Hansel D.E., Maitra A., Lin J.W., et al. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater. J Clin Oncol 23 (2005) 1811-1818
35. Yasui W., Oue N., Ito R., et al. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci 95 (2004) 385-392
36. Mallo G.V., Soubeyran P., Lissitzky J.C., et al. Expression of the Cdx1 and Cdx2 homeotic genes leads to reduced malignancy in colon cancer-derived cells. J Biol Chem 273 (1998) 14030-14036
37. Bai Y.Q., Miyake S., Iwai T., et al. CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene. Oncogene 22 (2003) 7942-7949
38. Uemura N., Okamoto S., Yamamoto S., et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345 (2001) 784-789
39. Faller G., and Kirchner T. Immunological and morphogenic basis of gastric mucosa atrophy and metaplasia. Virchows Arch 446 (2005) 1-9
40. Weydig C., Starzinski-Powitz A., Carra G., et al. CagA-independent disruption of adherence junction complexes involves E-cadherin shedding and implies multiple steps in Helicobacter pylori pathogenicity. Exp Cell Res 313 (2007) 3459-3471
41. Mizoshita T., Tsukamoto T., Nakanishi H., et al. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J Cancer Res Clin Oncol 129 (2003) 727-734